Clinical Trial Update: Pancreatic Cancer Diagnosis With FAPI-PET Imaging [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update evaluating FAPI-PET imaging for diagnosing pancreatic cancer, including staging and detection of recurrent disease, currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• FAPI-PET imaging tracer (Fibroblast Activation Protein Inhibitor (FAPI))

Snippet

Sponsor: Turku University Hospital | Conditions: Positron Emission Tomography, Pancreatic Cancer | Phase 2, Phase 3 | Status: RECRUITING